Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Obesity Topic Center

Featured Article

News
Few Medicare Providers Offer Intensive Behavioral Therapy for Obesity
10/23/2023
Jolynn Tumolo
Just 1% of primary care providers who cared for Medicare beneficiaries provided intensive behavioral therapy (IBT) for obesity at any time between 2013 and 2019, according to a study published online in PLOS One.
Just 1% of primary care providers who cared for Medicare beneficiaries provided intensive behavioral therapy (IBT) for obesity at any time between 2013 and 2019, according to a study published online in PLOS One.
Just 1% of primary care...
10/23/2023
First Report Managed Care
News
Obesity Drug Comparison Ranks Semaglutide Tops for Weight Loss, Waist Reduction
06/27/2023
Jolynn Tumolo
Semaglutide and phentermine/topiramate were associated with more weight loss and waist circumference reduction at 12 months compared with other obesity drugs, according to results from a systematic review and network meta-analysis. 
Semaglutide and phentermine/topiramate were associated with more weight loss and waist circumference reduction at 12 months compared with other obesity drugs, according to results from a systematic review and network meta-analysis. 
Semaglutide and...
06/27/2023
First Report Managed Care
News
BMI Improvement With Liraglutide Possible in Teens Regardless of Baseline Traits
06/23/2023
Jolynn Tumolo
“These results suggest that liraglutide may be a relevant treatment option for adolescents with obesity with an insufficient response to lifestyle therapy, irrespective of baseline characteristics,” wrote corresponding author Megan O...
“These results suggest that liraglutide may be a relevant treatment option for adolescents with obesity with an insufficient response to lifestyle therapy, irrespective of baseline characteristics,” wrote corresponding author Megan O...
“These results suggest that...
06/23/2023
First Report Managed Care
News
Subcutaneous Therapy Boosts Health-Related Quality of Life in Patients With Overweight, Obesity
05/25/2023
Jolynn Tumolo
Using data from four phase 3 clinical trials, researchers analyzed the impact of subcutaneous semaglutide, administered once weekly, on participants' health-related quality of life. 
Using data from four phase 3 clinical trials, researchers analyzed the impact of subcutaneous semaglutide, administered once weekly, on participants' health-related quality of life. 
Using data from four phase 3...
05/25/2023
First Report Managed Care
News
Study Finds Single-Anastomosis Sleeve Ileal Bypass Surgery Is Safe, Effective
05/23/2023
Julie Gould
According to study authors, “SASI bypass appears to be safe, and one of the most effective bariatric procedures regarding weight loss and obesity related comorbidities.”
According to study authors, “SASI bypass appears to be safe, and one of the most effective bariatric procedures regarding weight loss and obesity related comorbidities.”
According to study authors,...
05/23/2023
First Report Managed Care
News
Study Finds 9 of 10 Patients Did Not Fill Prescription for Antiobesity Medications
04/25/2023
Jolynn Tumolo
Researchers studied the demographics and clinical characteristics of real-world US patients to identify factors associated with primary nonadherence to obesity therapies.
Researchers studied the demographics and clinical characteristics of real-world US patients to identify factors associated with primary nonadherence to obesity therapies.
Researchers studied the...
04/25/2023
First Report Managed Care
News
Obesity, Metabolic Comorbidity Rates Up in Patients With Inflammatory Bowel Disease
04/21/2023
Jolynn Tumolo
Despite the prevalence of obesity and metabolic conditions increasing in patients with inflammatory bowel disease over the past decade, the prescription rate for anti-obesity medications has only slightly increased, researchers said.
Despite the prevalence of obesity and metabolic conditions increasing in patients with inflammatory bowel disease over the past decade, the prescription rate for anti-obesity medications has only slightly increased, researchers said.
Despite the prevalence of...
04/21/2023
First Report Managed Care
News
Bariatric Surgery Better Than Medical Therapy for Weight Loss, Metabolic Gain
12/21/2021
Jolynn Tumolo
For patients with obesity, bariatric surgery was linked with greater reductions in weight and improved metabolic parameters compared to medical therapy.
For patients with obesity, bariatric surgery was linked with greater reductions in weight and improved metabolic parameters compared to medical therapy.
For patients with obesity,...
12/21/2021
First Report Managed Care
News
One-Anastomosis Gastric Bypass Best Balances Metabolic Outcomes, Perioperative Safety
12/09/2021
Jolynn Tumolo
In a meta-analysis comparing outcomes among adults undergoing three types of weight loss surgery, one-anastomosis gastric bypass most optimally balanced weight loss and diabetes benefits with risk of complications.
In a meta-analysis comparing outcomes among adults undergoing three types of weight loss surgery, one-anastomosis gastric bypass most optimally balanced weight loss and diabetes benefits with risk of complications.
In a meta-analysis comparing...
12/09/2021
First Report Managed Care
News
Various Treatments Yield Sustained Reductions in Body Weight, Blood Pressure
11/24/2021
Jolynn Tumolo
Semaglutide and sodium-glucose co-transporter-2 inhibitors reduced body weight as well as diastolic and systolic blood pressure in patients with diabetes who had comorbid obesity and/or hypertension.
Semaglutide and sodium-glucose co-transporter-2 inhibitors reduced body weight as well as diastolic and systolic blood pressure in patients with diabetes who had comorbid obesity and/or hypertension.
Semaglutide and sodium-glucose...
11/24/2021
First Report Managed Care
News
Treatment Likely to Improve Quality of Life in Patients With Obesity
11/10/2021
Jolynn Tumolo
Authors noted the effectiveness of semaglutide in improving weight loss-related outcomes in patients with obesity, and also discussed cost challenges related to this treatment option.
Authors noted the effectiveness of semaglutide in improving weight loss-related outcomes in patients with obesity, and also discussed cost challenges related to this treatment option.
Authors noted the effectiveness...
11/10/2021
First Report Managed Care

Newsfeed

News
Few Medicare Providers Offer Intensive Behavioral Therapy for Obesity
10/23/2023
Jolynn Tumolo
Just 1% of primary care providers who cared for Medicare beneficiaries provided intensive behavioral therapy (IBT) for obesity at any time between 2013 and 2019, according to a study published online in PLOS One.
Just 1% of primary care providers who cared for Medicare beneficiaries provided intensive behavioral therapy (IBT) for obesity at any time between 2013 and 2019, according to a study published online in PLOS One.
Just 1% of primary care...
10/23/2023
First Report Managed Care
News
Obesity Drug Comparison Ranks Semaglutide Tops for Weight Loss, Waist Reduction
06/27/2023
Jolynn Tumolo
Semaglutide and phentermine/topiramate were associated with more weight loss and waist circumference reduction at 12 months compared with other obesity drugs, according to results from a systematic review and network meta-analysis. 
Semaglutide and phentermine/topiramate were associated with more weight loss and waist circumference reduction at 12 months compared with other obesity drugs, according to results from a systematic review and network meta-analysis. 
Semaglutide and...
06/27/2023
First Report Managed Care
News
BMI Improvement With Liraglutide Possible in Teens Regardless of Baseline Traits
06/23/2023
Jolynn Tumolo
“These results suggest that liraglutide may be a relevant treatment option for adolescents with obesity with an insufficient response to lifestyle therapy, irrespective of baseline characteristics,” wrote corresponding author Megan O...
“These results suggest that liraglutide may be a relevant treatment option for adolescents with obesity with an insufficient response to lifestyle therapy, irrespective of baseline characteristics,” wrote corresponding author Megan O...
“These results suggest that...
06/23/2023
First Report Managed Care
News
Subcutaneous Therapy Boosts Health-Related Quality of Life in Patients With Overweight, Obesity
05/25/2023
Jolynn Tumolo
Using data from four phase 3 clinical trials, researchers analyzed the impact of subcutaneous semaglutide, administered once weekly, on participants' health-related quality of life. 
Using data from four phase 3 clinical trials, researchers analyzed the impact of subcutaneous semaglutide, administered once weekly, on participants' health-related quality of life. 
Using data from four phase 3...
05/25/2023
First Report Managed Care
News
Study Finds Single-Anastomosis Sleeve Ileal Bypass Surgery Is Safe, Effective
05/23/2023
Julie Gould
According to study authors, “SASI bypass appears to be safe, and one of the most effective bariatric procedures regarding weight loss and obesity related comorbidities.”
According to study authors, “SASI bypass appears to be safe, and one of the most effective bariatric procedures regarding weight loss and obesity related comorbidities.”
According to study authors,...
05/23/2023
First Report Managed Care
News
Study Finds 9 of 10 Patients Did Not Fill Prescription for Antiobesity Medications
04/25/2023
Jolynn Tumolo
Researchers studied the demographics and clinical characteristics of real-world US patients to identify factors associated with primary nonadherence to obesity therapies.
Researchers studied the demographics and clinical characteristics of real-world US patients to identify factors associated with primary nonadherence to obesity therapies.
Researchers studied the...
04/25/2023
First Report Managed Care
News
Obesity, Metabolic Comorbidity Rates Up in Patients With Inflammatory Bowel Disease
04/21/2023
Jolynn Tumolo
Despite the prevalence of obesity and metabolic conditions increasing in patients with inflammatory bowel disease over the past decade, the prescription rate for anti-obesity medications has only slightly increased, researchers said.
Despite the prevalence of obesity and metabolic conditions increasing in patients with inflammatory bowel disease over the past decade, the prescription rate for anti-obesity medications has only slightly increased, researchers said.
Despite the prevalence of...
04/21/2023
First Report Managed Care
News
Bariatric Surgery Better Than Medical Therapy for Weight Loss, Metabolic Gain
12/21/2021
Jolynn Tumolo
For patients with obesity, bariatric surgery was linked with greater reductions in weight and improved metabolic parameters compared to medical therapy.
For patients with obesity, bariatric surgery was linked with greater reductions in weight and improved metabolic parameters compared to medical therapy.
For patients with obesity,...
12/21/2021
First Report Managed Care
News
One-Anastomosis Gastric Bypass Best Balances Metabolic Outcomes, Perioperative Safety
12/09/2021
Jolynn Tumolo
In a meta-analysis comparing outcomes among adults undergoing three types of weight loss surgery, one-anastomosis gastric bypass most optimally balanced weight loss and diabetes benefits with risk of complications.
In a meta-analysis comparing outcomes among adults undergoing three types of weight loss surgery, one-anastomosis gastric bypass most optimally balanced weight loss and diabetes benefits with risk of complications.
In a meta-analysis comparing...
12/09/2021
First Report Managed Care
News
Various Treatments Yield Sustained Reductions in Body Weight, Blood Pressure
11/24/2021
Jolynn Tumolo
Semaglutide and sodium-glucose co-transporter-2 inhibitors reduced body weight as well as diastolic and systolic blood pressure in patients with diabetes who had comorbid obesity and/or hypertension.
Semaglutide and sodium-glucose co-transporter-2 inhibitors reduced body weight as well as diastolic and systolic blood pressure in patients with diabetes who had comorbid obesity and/or hypertension.
Semaglutide and sodium-glucose...
11/24/2021
First Report Managed Care
News
Keratoconus Appears to be Associated With Demodex Mites
05/16/2024
Jolynn Tumolo
Keratoconus, an eye disorder that leads to gradual curvature of the cornea, may be associated with Demodex infestation, suggests a small study published in the Oman Journal of Ophthalmology.
Keratoconus, an eye disorder that leads to gradual curvature of the cornea, may be associated with Demodex infestation, suggests a small study published in the Oman Journal of Ophthalmology.
Keratoconus, an eye disorder...
05/16/2024
First Report Managed Care
News
Hospital Costs May Be Higher for Patients With Private Insurance
05/14/2024
Hannah Musick
A recent research report reveals that individuals with private health insurance pay 254% more for hospital procedures than Medicare rates, leading to potentially increased costs for millions of Americans.
A recent research report reveals that individuals with private health insurance pay 254% more for hospital procedures than Medicare rates, leading to potentially increased costs for millions of Americans.
A recent research report reveals...
05/14/2024
First Report Managed Care
News
Study Finds No Treatment-Related Adverse Events in Boys Treated With Purified FIX Concentrate
05/09/2024
Jolynn Tumolo
Purified factor IX (FIX) concentrate was effective in treating and preventing bleeding episodes in real-world pediatric patients 6 years and younger with hemophilia B, according to a study published in the Journal of Blood Medicine.
Purified factor IX (FIX) concentrate was effective in treating and preventing bleeding episodes in real-world pediatric patients 6 years and younger with hemophilia B, according to a study published in the Journal of Blood Medicine.
Purified factor IX (FIX)...
05/09/2024
First Report Managed Care
News
Demodex Infestation Found in 9 of 10 Eye Clinic Patients Using 2-Minute Technique
05/09/2024
Jolynn Tumolo
Demodex mites were found in the eyelashes of 94% of patients examined with a simple diagnostic technique at a standard ophthalmic practice, according to a study published online in the journal Clinical Ophthalmology.
Demodex mites were found in the eyelashes of 94% of patients examined with a simple diagnostic technique at a standard ophthalmic practice, according to a study published online in the journal Clinical Ophthalmology.
Demodex mites were found in the...
05/09/2024
First Report Managed Care
News
Debate Emerges Over FDA's Plan to Regulate Laboratory Medical Tests
05/03/2024
Hannah Musick
The FDA's new regulations on laboratory-developed tests have sparked debate over access to innovative tests and patient care in the medical field, with opponents arguing that increased oversight could hinder the development of crucial new...
The FDA's new regulations on laboratory-developed tests have sparked debate over access to innovative tests and patient care in the medical field, with opponents arguing that increased oversight could hinder the development of crucial new...
The FDA's new regulations on...
05/03/2024
First Report Managed Care
News
Analysis Shows Proposed CMS ‘Best Price’ Rule May Increase Rebate Liability, Impacting Medicaid
04/26/2024
Dean Celia
A proposed rule from Centers for Medicare & Medicaid Services (CMS), “Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program,” has been in the spotlight recently. Major health...
A proposed rule from Centers for Medicare & Medicaid Services (CMS), “Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program,” has been in the spotlight recently. Major health...
A proposed rule from Centers for...
04/26/2024
First Report Managed Care
News
Rebalancing Coagulation Pathways and Human Factor 9 Gene Knock-In Strategy Identified for Hemophilia B
04/25/2024

Grace Taylor

Grace Taylor
A study published in Molecular Therapy Nucleic Acids highlights a treatment strategy for treating hemophilia B by combining rebalancing coagulation pathways and human factor 9 (hF9) gene knock-in (KI) using a lipid nanoparticle and...
A study published in Molecular Therapy Nucleic Acids highlights a treatment strategy for treating hemophilia B by combining rebalancing coagulation pathways and human factor 9 (hF9) gene knock-in (KI) using a lipid nanoparticle and...
A study published in Molecular...
04/25/2024
First Report Managed Care
News
Neurologist Recognized for Pioneering MS Research and Treatment Strategies
04/24/2024
Hannah Musick
Dr Rhonda Voskuhl received the 2024 John Dystel prize for her groundbreaking research on sex differences in multiple sclerosis (MS), advancing women's health.
Dr Rhonda Voskuhl received the 2024 John Dystel prize for her groundbreaking research on sex differences in multiple sclerosis (MS), advancing women's health.
Dr Rhonda Voskuhl received the...
04/24/2024
First Report Managed Care
News
Chicago Sky Blue May be Considered as a Diagnostic Stain for Visualizing Demodex in Patients With Demodex Blepharitis
04/24/2024
Lisa Kuhns, PhD
Chicago sky blue is a promising stain that can identify and quantify the number of Demodex mites in patients with Demodex blepharitis, according to a study published in PeerJ.
Chicago sky blue is a promising stain that can identify and quantify the number of Demodex mites in patients with Demodex blepharitis, according to a study published in PeerJ.
Chicago sky blue is a promising...
04/24/2024
First Report Managed Care
News
Adverse Events Common With Glucocorticoids for Polymyalgia Rheumatica
04/17/2024
Jolynn Tumolo
Although glucocorticoid treatment reduced inflammatory parameters in real-world patients with polymyalgia rheumatica (PMR), more than a third still showed above-normal levels throughout a 52-week follow-up period, according to study results...
Although glucocorticoid treatment reduced inflammatory parameters in real-world patients with polymyalgia rheumatica (PMR), more than a third still showed above-normal levels throughout a 52-week follow-up period, according to study results...
Although glucocorticoid...
04/17/2024
First Report Managed Care

Advertisement

Advertisement

FRMC Volume 21, Issue 1

Current Issue

March 2024
Volume 21
Issue 1
Current Issue
Issue Archive

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement